Rani Therapeutics Holdings, Inc. reported preliminary estimates of having approximately $99 million in cash, cash equivalents, restricted cash equivalents, and marketable securities as of December 31, 2022.
AI Assistant
RANI THERAPEUTICS HOLDINGS INC
2023
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.